Wall Street stocks finished mixed on Monday as markets weigh hopes about reopening the economy against worries over coronavirus cases and the damage already inflicted by the shutdowns. The Dow Jones Industrial Average ended down 0.5 per cent at 24,221.99. The tech-rich Nasdaq Composite Index jumped 0.8 per cent to 9,192.34, while the broad-based S&P 500 ended essentially flat at 2,930.19.

Most US states have moved to reopen parts of their economy even as the national death toll approaches 80,000. Swathes of Europe, as well as New York, began the long process of reopening from coronavirus lockdowns on Monday, but a resurgence of infections in China and South Korea offered a sobering reminder of the dangers of a second wave of cases.

Oil prices fell on Monday as investors worried about a second wave of coronavirus infections, but new output cuts from Saudi Arabia tempered worries about oversupply and limited price losses.

Mapletree North Asia Commercial Trust will issue its scrip dividend at a price of S$0.8752 per unit, the manager said on Monday night. The price tag represents a roughly 1.9 per cent discount on the volume-weighted average traded unit price for all trades in the 10 market days up until the books closed on Monday, the manager added.

Deloitte flags 'going-concern' uncertainty in IEV Holdings financial statements.

Trek 2000 International will likely post a first-quarter net loss for the three months to March 31, the board disclosed on Monday. Based on a preliminary review of its unaudited results, the board blamed lower fair value of the group’s investments for the expected quarterly loss, as it fingered “the negative impact to the investment and equity market” from the deadly coronavirus pandemic.

The board of troubled Ezion Holdings has warned of “a significant net loss” for the first quarter to March 31, in a bourse filing issued on Monday night. The potential loss stems from an assessment of impairments on group assets. The assessment exercise was carried out after the coronavirus pandemic and plummeting oil prices “continued to adversely affect the reactivation and deployment plans of the group” and stymied its restructuring.

Hyphens Pharma International will reclassify its proposed final dividend for FY2019 as an interim dividend, as its annual general meeting, where shareholders would have voted on the payout, was delayed by the coronavirus pandemic. The books will now close on May 26, and shareholders can expect their payout of S$0.01 a share on June 8, Hyphens Pharma’s board said in a bourse filing on Monday.

Clearbridge Health will be a non-exclusive regional distributor of its Catalist-listed spin-off Biolidics’ coronavirus antibody test kits, according to bourse filings.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR